[GMAB]
Mid
Mid
2026-10-04 04:48:37
Genmab reports trial results for ovarian cancer drug candidate
Mid
2026-08-07 19:37:22
Genmab AS earnings beat by $0.15, revenue topped estimates
Mid
2026-07-13 20:26:25
H.C. Wainwright reiterates Genmab stock rating on FDA approval